Session 2: Which process and analytical tools have the requisite flexibility, scalability, and cost-effectiveness to enable rapid clinical translation while laying the groundwork for later development and commercialization? Part 2

Advanced Therapies Week 2027 · 19 January 2027 · 14:00–15:00 · Theatre 1

Session 2: Which process and analytical tools have the requisite flexibility, scalability, and cost-effectiveness to enable rapid clinical translation while laying the groundwork for later development and commercialization? Part 2 was a session at Advanced Therapies Week 2027 on 19 January 2027 in San Diego, with 3 speakers on record.

Speakers

• Josh Sorafine — Speaker Senior Vice President Quality and Analytics, Editas Medicine
• Damian Marshall — Speaker VP - Analytical Development, Resolution Therapeutics
• Mamta Kalra — Speaker Vice President Process and Analytical Development, Immatics